<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Telehealth</title>
    <description>
      <![CDATA[]]>
    </description>
    <link>https://www.bioworld.com/rss</link>
    <language>en-us</language>
    <item>
      <title>Pomdoctor closes $20M IPO to grow mobile health platform in China</title>
      <description>
        <![CDATA[Pomdoctor Ltd. raised $20 million through a Nasdaq IPO on Oct. 8, with the funds geared to expand its mobile health platform for chronic diseases in China.]]>
      </description>
      <guid>http://www.bioworld.com/articles/724830</guid>
      <pubDate>Fri, 10 Oct 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/724830-pomdoctor-closes-20m-ipo-to-grow-mobile-health-platform-in-china</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/Pomdoctor-10oct25.webp?t=1760130283" type="image/jpeg" medium="image" fileSize="248601">
        <media:title type="plain">Pomdoctor</media:title>
        <media:description type="plain">Pomdoctor</media:description>
      </media:content>
    </item>
    <item>
      <title>Device for monitoring wounds without removing dressings</title>
      <description>
        <![CDATA[Researchers from the University at Buffalo, the State University of New York (SUNY), filed for protection of their development of a new imaging technology that uses radar and AI to see through dressings to monitor wounds and other skin conditions.]]>
      </description>
      <guid>http://www.bioworld.com/articles/721129</guid>
      <pubDate>Wed, 18 Jun 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/721129-device-for-monitoring-wounds-without-removing-dressings</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/wound-monitoring-18jun25.webp?t=1750279614" type="image/jpeg" medium="image" fileSize="307849">
        <media:title type="plain">Wound Monitoring</media:title>
        <media:description type="plain">WO2025117987-A1, “System and method for non-contact epidermal sensing.”Assignee: The Research Foundation for The State University of New YorkInventors: Xu, Wenyao; Xia, Jun; Zhang, XiaoyuIPC codes: A61B 5/00; G06T 7/00; G06T 7/62; A61B 5/0507Publication date: June 5, 2025Earliest priority details: US2023604890, Nov. 30, 2023</media:description>
      </media:content>
    </item>
    <item>
      <title>Urine-testing device turns toilets into health trackers</title>
      <description>
        <![CDATA[In what represents just the company’s third PCT filing, Houston-based Starling Medical Inc.’s co-founders, Hannah McKenney and William Hendricks, seek to gain further protection for their at-home urine diagnostic patient-monitoring platform that eliminates the traditional use of catching containers and dipsticks.]]>
      </description>
      <guid>http://www.bioworld.com/articles/719944</guid>
      <pubDate>Fri, 16 May 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/719944-urine-testing-device-turns-toilets-into-health-trackers</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/urine-testing-device-16may25.webp?t=1747425021" type="image/jpeg" medium="image" fileSize="115210">
        <media:title type="plain">urine testing device</media:title>
        <media:description type="plain">WO2025090837-A1, “Bodily fluid management system.”Assignee: Starling Medical Inc.Inventors: McKenney, Hannah; Hendricks, William AndrewIPC codes: G01N 33/493; G01N 15/075; G01N 15/14; A61B 5/20; A61B 5/00; A61B 10/00Publication date: May 1, 2025Earliest priority details: US2023593148, Oct. 25, 2023</media:description>
      </media:content>
    </item>
    <item>
      <title>Updoc patents AI-powered diabetes management platform</title>
      <description>
        <![CDATA[The first patent from Palo Alto, Calif.-headquartered Updoc Inc. provides protection for their development of an artificially intelligent, voice-based method for prescribing, managing and administering at least one medication for management of type 2 diabetes to a patient.]]>
      </description>
      <guid>http://www.bioworld.com/articles/718652</guid>
      <pubDate>Thu, 03 Apr 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/718652-updoc-patents-ai-powered-diabetes-management-platform</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/updoc-3apr25.webp?t=1743716927" type="image/jpeg" medium="image" fileSize="164150">
        <media:title type="plain">Updoc</media:title>
        <media:description type="plain">US12251242-B1, “Voice-based method and system for management of type 2 diabetes.”Assignee: Updoc Inc.Inventors: Nayak, Ashwin K.; Vakili, SharifIPC dodes: A61B 5/00; A61B 5/145; G16H 40/67Publication date: Mar. 18, 2025Earliest priority details: US2023384321, Oct. 26, 2023</media:description>
      </media:content>
    </item>
    <item>
      <title>Toilets could be the next big health device: Medical Korea 2025</title>
      <description>
        <![CDATA[Seung-min Park, professor at Nanyang Technological University and cofounder of Kanaria Health, is working to manufacture smart bidets that can capture biomarker data from urine and stool automatically and enable continuous monitoring.]]>
      </description>
      <guid>http://www.bioworld.com/articles/717994</guid>
      <pubDate>Thu, 20 Mar 2025 11:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/717994-toilets-could-be-the-next-big-health-device-medical-korea-2025</link>
    </item>
    <item>
      <title>Congress eyes permanent telehealth measures in spending bill</title>
      <description>
        <![CDATA[The COVID-19 pandemic reset expectations of Medicare telehealth coverage, prompting a letter from dozens of members of Congress to Capitol Hill leadership asking for legislation that will memorialize telehealth benefits. But concerns over spending, fraud and abuse still hang over the discussion.]]>
      </description>
      <guid>http://www.bioworld.com/articles/715086</guid>
      <pubDate>Tue, 10 Dec 2024 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/715086-congress-eyes-permanent-telehealth-measures-in-spending-bill</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Geographic-regions/US/US-Capitol-and-100-bills.webp?t=1608670998" type="image/png" medium="image" fileSize="689551">
        <media:title type="plain">U.S. Capitol and $100 bills</media:title>
      </media:content>
    </item>
    <item>
      <title>MedPAC wary of Medicare software payment in fee-for-service care</title>
      <description>
        <![CDATA[The problems with U.S. Medicare coverage for medical software are well known, but the Medicare Payment Advisory Commission recently indicated that these problems are largely manageable for services delivered via managed care plans.]]>
      </description>
      <guid>http://www.bioworld.com/articles/709788</guid>
      <pubDate>Wed, 03 Jul 2024 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/709788-medpac-wary-of-medicare-software-payment-in-fee-for-service-care</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Regulatory/CMS-logo-and-website.webp?t=1689968782" type="image/jpeg" medium="image" fileSize="122536">
        <media:title type="plain">CMS logo and website</media:title>
      </media:content>
    </item>
    <item>
      <title>Smartheart study reveals drop in hospital readmissions, ED visits </title>
      <author>holland.johnson@clarivate.com</author>
      <description>
        <![CDATA[At the American College of Cardiology's (ACC) 24th Annual Scientific Session held this week in Atlanta, SHL Telemedicine Ltd. reported the full results of the Imperial College London TELE-ACS trial, the results of which were also published in the Journal of the American College of Cardiology.]]>
      </description>
      <guid>http://www.bioworld.com/articles/707169</guid>
      <pubDate>Fri, 12 Apr 2024 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/707169-smartheart-study-reveals-drop-in-hospital-readmissions-ed-visits</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2024/Smartheart-image-12apr24.webp?t=1712957129" type="image/jpeg" medium="image" fileSize="58601">
        <media:title type="plain">Smartheart image</media:title>
        <media:description type="plain">Visual Abstract from TELE-ACS trial presentation at ACC24</media:description>
      </media:content>
    </item>
    <item>
      <title>Proliferation of remote monitoring tech may swamp medical coding</title>
      <description>
        <![CDATA[The COVID-19 pandemic is well known for increasing telehealth utilization, including remote patient monitoring, but there are still issues with payer coverage policies even a year after the formal end of the public health emergency for COVID.]]>
      </description>
      <guid>http://www.bioworld.com/articles/705878</guid>
      <pubDate>Thu, 29 Feb 2024 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/705878-proliferation-of-remote-monitoring-tech-may-swamp-medical-coding</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Devices/remote-patient-monitoring-telehealth.webp?t=1648586460" type="image/png" medium="image" fileSize="208124">
        <media:title type="plain">Remote patient monitoring concept illustration</media:title>
      </media:content>
    </item>
    <item>
      <title>US OIG highlights hazards of telemedicine fraud in latest enforcement action</title>
      <description>
        <![CDATA[Advocates are pressing the U.S. Congress to pass legislation to require more Medicare coverage of telehealth and telemedicine, but the Office of Inspector General (OIG) continues to report instances of fraud in this area. OIG reported July 24 that government attorneys had forced a guilty plea out of a telemedicine provider who has agreed to pay $44 million to deal with charges of fraud perpetrated over a period of three and a half years.]]>
      </description>
      <guid>http://www.bioworld.com/articles/699336</guid>
      <pubDate>Tue, 25 Jul 2023 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/699336-us-oig-highlights-hazards-of-telemedicine-fraud-in-latest-enforcement-action</link>
    </item>
    <item>
      <title>US OIG announces crackdown on $2.5B in health care fraud</title>
      <description>
        <![CDATA[The U.S. Office of Inspector General (OIG) reported June 28 that it had launched a series of enforcement actions against perpetrators of a variety of forms of health care fraud, including in the areas of telemedicine and opioid abuse. The 78 individuals arraigned in this crackdown are said to be responsible for $2.5 billion.]]>
      </description>
      <guid>http://www.bioworld.com/articles/698494</guid>
      <pubDate>Fri, 30 Jun 2023 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/698494-us-oig-announces-crackdown-on-25b-in-health-care-fraud</link>
    </item>
    <item>
      <title>Telehealth Expansion Act passes first hurdle in US House Ways and Means</title>
      <description>
        <![CDATA[<p>Proponents of telehealth have been pressing Congress to statutorily broaden coverage of telehealth since before the COVID-19 pandemic, and the Telehealth Expansion Act of 2023 carries the weight of at least some of these expectations. The House Ways and Means Committee’s health subcommittee recently voted 30-12 to pass along the legislation to the full committee, but the bill operates principally to allow high-deductible health plans to cover telehealth benefits before the enrollee has met the deductible, leaving a substantial amount of telehealth terrain unaddressed.</p>]]>
      </description>
      <guid>http://www.bioworld.com/articles/697784</guid>
      <pubDate>Thu, 08 Jun 2023 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/697784-telehealth-expansion-act-passes-first-hurdle-in-us-house-ways-and-means</link>
    </item>
    <item>
      <title>New interoperability and safety guidelines come into force affecting medical devices in France</title>
      <description>
        <![CDATA[France is tightening access to the reimbursed health care market for digital medical devices. The national Digital Healthcare Agency (ANS) reported that a standard interoperability and safety system for digital medical devices is coming into force.]]>
      </description>
      <guid>http://www.bioworld.com/articles/695728</guid>
      <pubDate>Mon, 03 Apr 2023 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/695728-new-interoperability-and-safety-guidelines-come-into-force-affecting-medical-devices-in-france</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Geographic-regions/Europe/France-binary-flag-digital.webp?t=1622585708" type="image/png" medium="image" fileSize="1946308">
        <media:title type="plain">French flag composed of binary code</media:title>
      </media:content>
    </item>
    <item>
      <title>First telemedicine drone delivers consultations in Pakistan</title>
      <description>
        <![CDATA[Drones are now being used for medical consultations and facilitating remote diagnosis, potentially leveraging telemedicine technology to improve health care outcomes in remote locations that cannot be easily accessed. Telemedicine consultations using aerial drones are about to become commonplace in Pakistan, and possibly around the world, according to Shariq Khoja, CEO of Tech4Life Enterprises.]]>
      </description>
      <guid>http://www.bioworld.com/articles/694791</guid>
      <pubDate>Fri, 03 Mar 2023 13:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/694791-first-telemedicine-drone-delivers-consultations-in-pakistan</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2023/Tech4life-drone.webp?t=1677882205" type="image/png" medium="image" fileSize="1510190">
        <media:title type="plain">Tech4life drone on table</media:title>
        <media:description type="plain">Telemedicine drones could be used for disaster response and military organizations, as well as providing health care in remote areas. Credit: Tech4life Enterprises</media:description>
      </media:content>
    </item>
    <item>
      <title>Nuralogix launches telehealth feature for AI facial scan app</title>
      <description>
        <![CDATA[Nuralogix Corp. is taking its selfie-based health monitoring platform to the next level, offering continuous health and vital signs tracking during video calls. The launch of Anura Telehealth is the newest addition its Anura app, which uses video cameras on smartphones and other consumer devices to extract facial blood flow information and provide a personalized snapshot of health and wellness.]]>
      </description>
      <guid>http://www.bioworld.com/articles/693059</guid>
      <pubDate>Fri, 06 Jan 2023 13:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/693059-nuralogix-launches-telehealth-feature-for-ai-facial-scan-app</link>
    </item>
    <item>
      <title>Russia looks to expand its influence through health care</title>
      <description>
        <![CDATA[Citing “the current political conditions,” Russian Minister of Health Mikhail Murashko laid out ways for Russia to strengthen its international role in the health care sector, including the development of innovative radiopharmaceuticals. Other promising opportunities involve the improvement of drug provision and an increase in the number of foreign students in Russian medical universities, Murashko said at a July 19 meeting with medical, educational and scientific institutions in Russia.]]>
      </description>
      <guid>http://www.bioworld.com/articles/520956</guid>
      <pubDate>Fri, 22 Jul 2022 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/520956-russia-looks-to-expand-its-influence-through-health-care</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Geographic-regions/Europe/europe-map.webp?t=1588688099" type="image/png" medium="image" fileSize="511811">
        <media:title type="plain">Map of Europe</media:title>
      </media:content>
    </item>
    <item>
      <title>Telehealth, digital health on tap in draft Medicare doc fee schedule for CY 2023</title>
      <description>
        <![CDATA[The U.S. CMS posted the draft Medicare physician fee schedule (MPFS) for calendar year 2023, and advocates of telehealth will be cheered by a proposed extension of some pandemic-driven telehealth services throughout 2023. The draft is less generous in connection with external electrocardiogram patches in a move that could ding Irhythm Technologies Inc., and its Zio XT device, but analysts at BTIG predict that any hit to reimbursement rates is likely to be offset with greater sales volumes, leaving Irhythm and its investors in a solid place going forward.]]>
      </description>
      <guid>http://www.bioworld.com/articles/520626</guid>
      <pubDate>Mon, 11 Jul 2022 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/520626-telehealth-digital-health-on-tap-in-draft-medicare-doc-fee-schedule-for-cy-2023</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Geographic-regions/US/US-budget-spending-money.webp?t=1588689236" type="image/png" medium="image" fileSize="1809708">
        <media:title type="plain">U.S. flag and money</media:title>
      </media:content>
    </item>
    <item>
      <title>Stakeholders prod US Congress for permanent Medicare telehealth benefits</title>
      <description>
        <![CDATA[The COVID-19 pandemic shone a bright light on the need for and utility of telehealth, which in turn prompted the U.S. Centers for Medicare & Medicaid Services (CMS) to temporarily expand telehealth coverage. Some of those coverage policies are set to expire when the public health emergency ends, and a group of stakeholders, including the American College of Cardiology, are urging Congress to pass legislation that would make some of these benefits permanent, a potential boon for many telehealth entities.]]>
      </description>
      <guid>http://www.bioworld.com/articles/515707</guid>
      <pubDate>Wed, 02 Feb 2022 13:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/515707-stakeholders-prod-us-congress-for-permanent-medicare-telehealth-benefits</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Devices/digital-health-telehealth-phone-doctor.webp?t=1595547749" type="image/png" medium="image" fileSize="743872">
        <media:title type="plain">Telehealth illustration</media:title>
      </media:content>
    </item>
    <item>
      <title>Qardio predicts 2022 as pivotal year for RPM growth</title>
      <description>
        <![CDATA[With a new CEO at the helm, remote patient monitoring (RPM) company Qardio Inc. believes 2022 can be a pivotal year to drive adoption of its 4G and Bluetooth-enabled cardiac solutions. The San Francisco-based company recently launched Qardiocore, an ambulatory ECG, and Qardiodirect, an end-to-end remote patient monitoring and telehealth service.]]>
      </description>
      <guid>http://www.bioworld.com/articles/514676</guid>
      <pubDate>Wed, 29 Dec 2021 13:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/514676-qardio-predicts-2022-as-pivotal-year-for-rpm-growth</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2021/12-29-Qardio-Qardiocore.webp?t=1640809734" type="image/png" medium="image" fileSize="1471965">
        <media:title type="plain">Man on jog with Qardiocore device around chest</media:title>
        <media:description type="plain">Qardiocore, an ambulatory ECG remote patient monitoring system. Credit: Qardio Inc.</media:description>
      </media:content>
    </item>
    <item>
      <title>Vicentra secures $74M to push Kaleido insulin pump in Europe </title>
      <description>
        <![CDATA[Vicentra BV has closed a $74 million series C financing round to accelerate the European rollout of its wearable insulin patch. The small, lightweight system Kaleido is the company’s flagship product and consists of two pumps controlled by a Bluetooth wireless connected handset. The small size rests on a pumping action that – unlike a conventional syringe mechanism – uses micro-pulse technology to deliver accurate and consistent doses of insulin.]]>
      </description>
      <guid>http://www.bioworld.com/articles/514379</guid>
      <pubDate>Fri, 17 Dec 2021 13:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/514379-vicentra-secures-74m-to-push-kaleido-insulin-pump-in-europe-catherine-longworth</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Diabetes/pancreas-insulin-diabetic.webp?t=1588881992" type="image/png" medium="image" fileSize="410518">
        <media:title type="plain">Pancreas illustration</media:title>
      </media:content>
    </item>
    <item>
      <title>Ophthalmic Sciences eyes 2023 for launch of AI device for glaucoma</title>
      <description>
        <![CDATA[Israeli startup Ophthalmic Sciences Ltd. is targeting 2023 for regulatory clearance of its artificial intelligence (AI)-based contactless intraocular pressure (IOP) measuring device, IO Perfect. The technology, which combines AI visual analysis in a virtual reality headset, enables remote monitoring of glaucoma. The device is designed to be used at home, in eye clinics, emergency room departments, pharmacies and primary physician settings.]]>
      </description>
      <guid>http://www.bioworld.com/articles/514003</guid>
      <pubDate>Mon, 06 Dec 2021 13:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/514003-ophthalmic-sciences-eyes-2023-for-launch-of-ai-device-for-glaucoma</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2021/12-06-Ophthalmic-Sciences-VR-headset.webp?t=1638831375" type="image/png" medium="image" fileSize="569056">
        <media:title type="plain">Man wearing Ophthalmic Sciences' VR headset</media:title>
        <media:description type="plain">Ophthalmic Sciences' device combines AI visual analysis in a virtual reality headset to enable remote monitoring of glaucoma. Credit: Ophthalmic Sciences Ltd.</media:description>
      </media:content>
    </item>
    <item>
      <title>Sword Health cuts through crowded MSK field to win $189M</title>
      <description>
        <![CDATA[Sword Health Technologies Inc. slipped another $189 million into its coffers with an oversubscribed $163 million series D fundraising round that spilled into an additional $26 million secondary transaction. The enthusiasm for the round points to the keen interest in digital delivery of musculoskeletal (MSK) physical therapy, which has driven Sword and competitor Hinge Health Inc. both into rarified unicorn territory with valuations of $2 billion and $6.2 billion, respectively.]]>
      </description>
      <guid>http://www.bioworld.com/articles/513684</guid>
      <pubDate>Tue, 23 Nov 2021 13:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/513684-sword-health-cuts-through-crowded-msk-field-to-win-189m</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2021/11-23-Sword-Health-MSK.webp?t=1637707158" type="image/png" medium="image" fileSize="303453">
        <media:title type="plain">Patient using Sword Health devices for digital physical therapy</media:title>
        <media:description type="plain">Sword Health Technologies Inc. provides digital musculoskeletal care.</media:description>
      </media:content>
    </item>
    <item>
      <title>Stakeholders jeer Medicare physician fee final for 2022, but telehealth scores a win</title>
      <description>
        <![CDATA[The U.S. CMS waded into controversy with two final rules calendar year 2022, drawing fire from device makers and doctors who allege that cuts in rates for physicians will hamper beneficiary access. Software developers working in the telehealth space will find much to cheer, however, given that some telehealth services that were covered during the COVID-19 pandemic will be covered after the pandemic has passed.]]>
      </description>
      <guid>http://www.bioworld.com/articles/513002</guid>
      <pubDate>Wed, 03 Nov 2021 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/513002-stakeholders-jeer-medicare-physician-fee-final-for-2022-but-telehealth-scores-a-win</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Geographic-regions/US/US-health-flag-medicare.webp?t=1629754472" type="image/png" medium="image" fileSize="585251">
        <media:title type="plain">U.S. flag, stethoscope</media:title>
      </media:content>
    </item>
    <item>
      <title>Alivecor taps blockchain technology to connect Kardiamobile users with physicians</title>
      <description>
        <![CDATA[Alivecor Inc. is partnering with blockchain technology company Solve.Care to connect users of its Kardiamobile device to physicians through a telehealth network. Tallinn, Estonia-based Solve.Care’s blockchain platform, the Global Telehealth Exchange (GTHE), is an open global cross-border telehealth network currently available in 27 countries. Alivecor’s Kardiamobile 6L device is the first and only six-lead personal ECG cleared by the FDA. Through the partnership, Kardiamobile devices will be integrated with GTHE where physicians will be able to access a user’s electrocardiogram (ECG) reading upon their consent through teleconsultations.]]>
      </description>
      <guid>http://www.bioworld.com/articles/512802</guid>
      <pubDate>Wed, 27 Oct 2021 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/512802-alivecor-taps-blockchain-technology-to-connect-kardiamobile-users-with-physicians</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Devices/digital-blockchain-security.webp?t=1589220503" type="image/png" medium="image" fileSize="1585540">
        <media:title type="plain">Chain links composed of binary code</media:title>
      </media:content>
    </item>
    <item>
      <title>EY Pulse: Three ways med-tech companies can capitalize on pandemic shifts</title>
      <description>
        <![CDATA[The Ernst & Young Pulse of the Industry 2021 report outlined several ways med-tech companies can benefit from fundamental changes in business wrought by the pandemic to build a stronger foundation for the future. While the need for more agile supply chains and the drive to measure social and environmental impact as well as financial metrics have affected all economic sectors, COVID-19 transformed the med-tech industry in specific ways that could have long-lasting impact.]]>
      </description>
      <guid>http://www.bioworld.com/articles/512357</guid>
      <pubDate>Wed, 13 Oct 2021 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/512357-ey-pulse-three-ways-med-tech-companies-can-capitalize-on-pandemic-shifts</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Devices/thumb/telehealth-telemed-online-doctor.webp?t=1585948502" type="image/png" medium="image" fileSize="89703">
        <media:title type="plain">telehealth-telemed-online-doctor.png</media:title>
      </media:content>
    </item>
    <item>
      <title>AI or crystal ball? Panel predicts the future of digital health post-pandemic</title>
      <description>
        <![CDATA[Software-as-a-medical device (SaMD) came into its own during the pandemic as digital health applications enabled patients to receive care from home through telemedicine, apps and remote patient monitoring. At the 2021 Medtech Conference, a panel of regulators, advocates and digital health executives discussed how the last 18 months may permanently change the regulation of these devices, the steps manufacturers can take to secure the footholds they gained, and how the U.S. CMS can enable digital health to achieve its promise.]]>
      </description>
      <guid>http://www.bioworld.com/articles/512036</guid>
      <pubDate>Mon, 04 Oct 2021 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/512036-ai-or-crystal-ball-panel-predicts-the-future-of-digital-health-post-pandemic</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Devices/connected-digital-health.webp?t=1589385444" type="image/png" medium="image" fileSize="397881">
        <media:title type="plain">Laptop, stethoscope, medical icons, health professional</media:title>
      </media:content>
    </item>
    <item>
      <title>Singapore startup Doctor Anywhere banks $88M for telehealth expansion</title>
      <description>
        <![CDATA[Health-tech startup Doctor Anywhere Ltd. (DA) has raised $88 million in series C fundraising, as the telehealth sector continues to be attractive for investors. The round is one of the largest private investments ever raised by a Southeast Asian digital health company and was led by growth equity investor Asia Partners. Novo Holdings, Philips, OSK-SBI Venture Partners, EDBI, Square Peg, IHH Healthcare, Kamet Capital and Pavilion Capital also participated.]]>
      </description>
      <guid>http://www.bioworld.com/articles/511054</guid>
      <pubDate>Thu, 02 Sep 2021 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/511054-singapore-startup-doctor-anywhere-banks-88m-for-telehealth-expansion</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Money/financings-international-foreign-currency.webp?t=1751908080" type="image/png" medium="image" fileSize="509882">
        <media:title type="plain">International currency symbols</media:title>
      </media:content>
    </item>
    <item>
      <title>Opya nabs $15.4M in series A fundraising</title>
      <description>
        <![CDATA[Opya Inc., a provider of integrated autism services, secured $15.4 million in a series A fundraising round. New investors in the round included Panoramic Ventures, Softbank&rsquo;s Opportunity Fund, Disability Opportunity Fund, and Raven One Ventures. Divergent Investments and Altitude Ventures added to their existing investments in the company.]]>
      </description>
      <guid>http://www.bioworld.com/articles/510585</guid>
      <pubDate>Wed, 18 Aug 2021 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/510585-opya-nabs-154m-in-series-a-fundraising</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Money/3D-dollar-sign.webp?t=1624487200" type="image/png" medium="image" fileSize="316216">
        <media:title type="plain">3D dollar sign</media:title>
      </media:content>
    </item>
    <item>
      <title>Telemedicine company charged with filing $784M in false claims for DME</title>
      <description>
        <![CDATA[The frequent calls for an expansion of telemedicine have come with relatively hushed advisories about the potential for fraud, concerns that have been borne out by an indictment recently returned by a federal grand jury in New Jersey. A company that presented itself as a provider of telemedicine services has been charged with filing $784 million in false claims for unnecessary durable medical equipment.]]>
      </description>
      <guid>http://www.bioworld.com/articles/510385</guid>
      <pubDate>Thu, 12 Aug 2021 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/510385-telemedicine-company-charged-with-filing-784m-in-false-claims-for-dme</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Devices/digital-health-telehealth-phone-doctor.webp?t=1595547749" type="image/png" medium="image" fileSize="743872">
        <media:title type="plain">Telehealth illustration</media:title>
      </media:content>
    </item>
    <item>
      <title>CMS proposes to extend some U.S. telehealth coverage through the end of 2023</title>
      <description>
        <![CDATA[Medicare coverage of telehealth services in the U.S. received a boost during the COVID-19 pandemic, a change that stakeholders have argued should be made permanent. The Centers for Medicare &amp; Medicaid Services (CMS) has proposed to extend coverage of some of these services throughout calendar year 2023 in the draft Medicare physician fee schedule, but some stakeholders are urging Congress to act before the end of the year to make these benefits permanent.]]>
      </description>
      <guid>http://www.bioworld.com/articles/509327</guid>
      <pubDate>Wed, 14 Jul 2021 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/509327-cms-proposes-to-extend-some-us-telehealth-coverage-through-the-end-of-2023</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Devices/telehealth-telemed-online-doctor.webp?t=1588280443" type="image/png" medium="image" fileSize="233710">
        <media:title type="plain">Telehealth illustration</media:title>
      </media:content>
    </item>
  </channel>
</rss>
